GOLDMAN SACHS GROUP INC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 25 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2022$7,000
-41.7%
12,615
-35.8%
0.00%
Q4 2021$12,000
-95.5%
19,636
-91.9%
0.00%
Q2 2021$266,000
+109.4%
241,991
+300.6%
0.00%
Q1 2019$127,000
+2.4%
60,404
+70.7%
0.00%
Q1 2018$124,000
+34.8%
35,382
+68.8%
0.00%
Q4 2017$92,000
+61.4%
20,955
+42.6%
0.00%
Q3 2015$57,000
-50.4%
14,694
-46.2%
0.00%
Q2 2015$115,000
+7.5%
27,331
+0.2%
0.00%
Q1 2015$107,000
-75.3%
27,266
-61.1%
0.00%
Q4 2014$433,000
+9.9%
70,098
-16.7%
0.00%
Q3 2014$394,000
-3.7%
84,162
-1.0%
0.00%
Q2 2014$409,000
-2.4%
85,050
+29.1%
0.00%
Q1 2014$419,00065,8940.00%
Other shareholders

There were no reported owners of ADAMIS PHARMACEUTICALS CORP in Q4 2015.

NameSharesValueWeighting ↓
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders